Infinity Pharmaceuticals

Infinity Pharmaceuticals Cash Conversion

The Cash Conversion Rate (OCF/Net Income) of Infinity Pharmaceuticals (INFIQ) as of Nov 20, 2026 is 95.63 %. In the previous year, Cash Conversion Rate (OCF/Net Income) was 89.74 % — a change of 6.57% (higher).

Cash Conversion

95.63 %

YoY

6.57%

Last updated:

Cash Conversion Rate (OCF/Net Income) of Infinity Pharmaceuticals is 2022 95.63 % . Cash Conversion Rate (OCF/Net Income) of Infinity Pharmaceuticals was 2021 89.74 % . It decreases by 6.57% higher compared to the previous year.

The Infinity Pharmaceuticals Cash Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Cash Conversion
Date
Cash Conversion
Jan 1, 2015
65.19 USD
Jan 1, 2016
512.96 USD
Jan 1, 2017
87.80 USD
Jan 1, 2018
41.59 USD
Jan 1, 2019
88.25 USD
Jan 1, 2020
88.26 USD
Jan 1, 2021
89.74 USD
Jan 1, 2022
95.63 USD
The Infinity Pharmaceuticals Cash Conversion history
YEARCash ConversionYoY
95.63 %+6.57%
89.74 %+1.67%
88.26 %+0.01%
88.25 %+112.19%
41.59 %-52.63%
87.80 %-82.88%
512.96 %+686.90%
65.19 %-109.64%
-676.44 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Infinity Pharmaceuticals Stock analysis

What does Infinity Pharmaceuticals do? Infinity Pharmaceuticals Inc. is a biopharmaceutical company based in Cambridge, Massachusetts. It was founded in 2001 and focuses on the discovery and development of novel therapies for cancer and other serious diseases. Infinity Pharmaceuticals is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Infinity Pharmaceuticals stock

Cash Conversion Rate (OCF/Net Income) of Infinity Pharmaceuticals is 95.63 % in 2022.

Cash Conversion Rate (OCF/Net Income) of Infinity Pharmaceuticals changed from 89.74 % to 95.63 %, representing a 6.57% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Cash Conversion Rate (OCF/Net Income) Infinity Pharmaceuticals since 2006 – with annual values, charts, and detailed analysis.

Cash conversion measures how effectively net income converts to operating cash flow. Ratios above 100% indicate high-quality, cash-backed earnings.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Cash Conversion Rate (OCF/Net Income)'s Infinity Pharmaceuticals with sector peers and the industry average to assess whether it is attractive.

To evaluate Cash Conversion Rate (OCF/Net Income)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Cash Conversion Rate (OCF/Net Income).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Infinity Pharmaceuticals

All Key Metrics — Infinity Pharmaceuticals